Abstract

Objective: Herpes zoster (HZ) is caused by reactivation of latent varicella zoster virus that resides in a dorsal root ganglion. HZ is rare in immunocompetent children. The purpose of this study was to evaluate the demographic features, clinical manifestations and complications of children diagnosed as HZ at our dermatology clinic.

Material and Methods: Patients under 18 years who presented with HZ to our dermatology clinic between October 2012 and September 2013 were retrospectively investigated. Age, gender, history of chickenpox, varicella vaccination, predisposing factors, clinical manifestations, associated diseases, use of immunosuppressive drugs, month of onset, complications and treatment were evaluated.results: Among the 24 patients diagnosed with HZ, 8 were girls (33.3%) and 16 were boys (66.6%). The median age was 13 years (2-17 years). While 16 (66.6%) patients had thoracic dermatome involvement, the rest had cervical (n=3, 12.5%), cervicothoracic (n=2, 8.3%), lumbar (n=3, 12.5%) dermatome involvement. None of the patients had disseminated eruption. Eight patients had local lymphadenopathy. All patients had pruritus and/or pain and eighteen patients had both pruritus and pain. Eleven patients had triggering factors such as emotional stress (originating from school or home), surgery, febrile illness and fasting. None of the patients had immunosuppression. HZ occurred in all seasons but most commonly in February. None of the patients had undergone varicella vaccination. A history of chickenpox was recorded in only 8 (%33.3) patients. Fifteen patients (%62.5) were given systemic antiviral treatment. Postherpetic neuralgia or major complications were not observed. conclusion: HZ can be seen in healthy children. Similar to adults, the common places of involvement are thoracic dermatomes. Stress, surgery, febrile illness and long-term hunger such as fasting can facilitate the development of HZ in healthy children. Postherpetic neuralgia or major complications do not usually occur in healthy children

Keywords: Child, Herpes zoster, Varicella-zoster virus

References

  1. Mendoza N, Madkan V, Sra K, Willison B, Morrison LK, Tyring SK. Human Herpes viruses. In: Bolognia JL, Jorizzo JL, Schaffer JV (eds). Dermatology. 3rd ed. China: Elsevier Saunders 2012;1321- 43.
  2. McCrary ML, Severson J, Tyring SK. Varicella zoster virus. J Am Acad Dermatol 1999;41:1-14.
  3. Ramdass P, Mullick S, Farber HF. Viral skin diseases. Prim Care 2015;42:517-67.
  4. Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: A multidisciplinary perspective. Ther Adv Vaccines 2015;3:109-20.
  5. Feder HM, Hoss DM. Herpes zoster in otherwise healthy children. Pediatr Infect Dis J 2004;23:451-7.
  6. Kurlan JG, Connelly BL, Lucky AW. Herpes zoster in the first year of life following postnatal exposure to varicella-zoster virus: Four case reports and a review of infantile herpes zoster. Arch Dermatol 2004;140:1268-72.
  7. Özuğuz P, Kaçar SD, Polat S, Karaca S, Kundak A. Çocukluk çağı zona zoster: 12 olgu sunumu. Abant Medical Journal 2014;3:253- 6.
  8. Tepe B, Bucak İH, Almış H. Sağlıklı çocuklarda herpes zoster: Retrospektif bir çalışma. Turk J Dermatol 2016;10:65-9.
  9. Grote V, vonKries R, Rosenfeld E, Belohradsky BH, Liese J. Immunocompetent children account for the majority of complications in childhood herpes zoster. J Infect Dis 2007;196:1455-8.
  10. Goh CL, Khoo L. A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int J Dermatol 1997;36:667-72.
  11. Saçar H, Uyar B, Saçar T. Suçiçeği aşısı sonrası gelişen herpes zoster olgusu. Dermatoz 2014;5:1-4.
  12. Topkarcı Z, Erdoğan B, Erkum T, Yılmaz M. Sağlıklı çocuklarda herpes zoster infeksiyonu. Bakırköy Tıp Dergisi 2012;8:178-81.
  13. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007;44(Suppl 1):S1-26.
  14. Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc 2009;84:274-80.
  15. Katakam BK, Kiran G, Kumar U. A prospective study of herpes zoster in children. Indian J Dermatol 2016;61:534-9.
  16. A ve ark. Önceden sağlıklı çocuklarda Türkiye ulusal bağışıklama çizelgesinde (Ulusal Aşı Takvimi) yer alan ve almayan aşılara ilişkinuygulama önerileri-2015. J Pediatr Inf 2015;9:1-11.
  17. Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J Infect Dis 2013;208:1859-68.

How to cite

1.
Güven M, Bozkurt EÇ. Herpes Zoster Infection in Childhood: An Evaluation of 24 Cases. Turk J Pediatr Dis [Internet]. 2017 Dec. 1 [cited 2025 May 24];11(4):233-8. Available from: https://turkjpediatrdis.org/article/view/423